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1. Introduction
  Urinary tract infections (UTI) represent the most common 
bacterial infection in pregnancy[1] and are classed as either 
asymptomatic or symptomatic[2]. The original criterion 
for diagnosing bacteriuria was >105 CFU/mL of a single 
uropathogen on two consecutive clean catch samples, with a 
95% probability of significant bacteriuria[3].  The detection 
of >105 CFU/mL of a single uropathogen in a single 
voided midstream urine is accepted as a more practical 
and adequate alternative, although there is only an 80% 
probability of true bacteriuria.
  Though asymptomatic bacteriuria (ASB) in non-
pregnant women is generally benign, pregnant women 
with bacteriuria have an increased susceptibility to 
pyelonephritis[4], and the incidence of acute pyelonephritis 
in pregnant women with ASB is significantly increased. 
  Testing for the presence of micro-organisms in the urinary 
tract, in order to diagnose ASB or symptomatic UTI (UTI), is 
very common at all levels of health care[5]. Screening for and 
treatment of ASB in pregnancy has become a standard of 
obstetric care and most antenatal guidelines include routine 
screening for asymptomatic bacteriuria[6]. The current 
recommendation is to obtain a urine culture between 12-
16 weeks of gestation and pregnant women in whom ASB 
is detected should be treated with antibiotics targeting the 
cultured organism, and they should undergo follow-up 
monitoring[7].
  The combination of mechanical, hormonal and physiologic 
changes during pregnancy contributes to significant 
changes in the urinary tract, which has a profound impact 
on the acquisition, and natural history of bacteriuria 
during pregnancy[1]. The renal pelvis and ureters begin 
to dilate as early as the eighth week of pregnancy[8]. 
Additionally, the physiologic increase in plasma volume 
during pregnancy decreases urine concentration and 
increases urinary progestins and estrogens, which may lead 
to a decreased ability of the lower urinary tract to resist 
invading bacteria[1]. Differences in urine pH and osmolality 
and pregnancy-induced glycosuria and aminoaciduria may 
facilitate bacterial growth[9].
  The prevalence of ASB in pregnancy from literature 
is 2-11% [10], when it can progress to symptomatic UTI, 
postpartum UTI or pyelonephritis. The prevalence of 
bacteriuria in pregnancy is associated with a history of 
recurrent urinary tract infections, diabetes, anatomical 
abnormalities of the urinary tract, and host factors: race, 
sickle cell disease, age and parity[11]. Untreated bacteriuria 
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during pregnancy has been shown to be associated with 
low birth-weight and premature delivery[12], and treatment 
for ASB reduces the incidence of symptomatic urinary tract 
infections, low-birth weight children, and preterm delivery. 
The antibiotic chosen should have a good maternal and fetal 
safety profile, excellent efficacy and low resistance rates in 
a given population.
  Many screening tests are available for the diagnosis of 
bacteriuria. An ideal test requires only limited technical 
expertise, is cheap and has a high accuracy, enabling a 
quick diagnosis in high-risk patients. Although urine 
cultures are expensive, require laboratory expertise and take 
24-48 hours for results to become available, quantitative 
culture remains the gold standard for diagnosis of urinary 
tract infection in pregnancy because it has high sensitivity 
and negative predictive value in this population, and the 
performance of rapid urine screening tests in pregnancy is 
poor[13].
  The biochemical reagent strip test (dipstick test) operates 
by detection of a leucocyte esterase (LE) and a nitrate 
reductase(NR) activity. These tests have poor negative 
predictive values to detect bacteriuria in asymptomatic 
persons[14]. Disparities in urine collection and analysis, 
and patient selection may influence the presence of micro-
organisms which can be detected by the dipstick, as well 
as the presence of substances that may give false results[15]. 
The dipstick test for NR had its highest accuracy and lowest 
sensitivity in pregnant women[5]. Sensitivity of the urine 
dipstick test for leukocyte-esterase was slightly higher than 
for the dipstick test for NR, while the specificity was slightly 
lower[5], and combining the results of both parts of the 
dipstick tests should logically increase sensitivity. Though 
the presence of nitrite is highly specific for bacteria, several 
uropathogens do not reduce nitrate to nitrite, and therefore 
its utility is restricted to enterobacteriaceae which reduce 
nitrate to nitrite and give a positive test result[3]. 
  This study focuses on the prevalence of ASB in pregnant 
women attending the antenatal clinic of the University 
of Port Harcourt Teaching Hospital, identification of the 
uropathogens involved and their antimicrobial sensitivity 
patterns, and to evaluate the diagnostic efficacy of urinalysis 
in screening for ASB among pregnant women.
2. Materials and methods
2.1. Study population
  A descriptive cross sectional design was adopted and a 
stratified sampling method was used, with a working sample 
size of 800. Ethical approval for this study was obtained from 
the relevant authorities. The sample size was obtained using 
Kish formula[15]. Inclusion criteria were apparently healthy 
pregnant females attending the antenatal clinic at UPTH 
between January and June 2009. Exclusion criteria was 
pregnant women who presented with any recent history of 
antibiotic therapy or any two of the following genitourinary 
complaints: dysuria, urinary hesitancy, urgency, slow stream, 
incontinence, frequency, incomplete voiding, and flank, 
suprapubic, or hypogastric pain. However, the symptoms 
of frequency, urgency and nocturia are not specific for an 
infectious process and are commonly described by pregnant 
women in the absence of a urinary tract infection[16,17]. 
2.2. Collection and analysis of sample
Mid stream, clean catch urine samples were collected and 
immediately analysed. The patients were instructed on 
how to collect the samples into sterile universal bottles 
containing 1% boric acid to stem overt multiplication 
of bacterial cells. Combi-9 biochemical reagent strips 
(dipsticks) were used to screen for the presence of NR and 
LE activity.
2.3. Culture and microscopy
  A semi-quantitative technique was employed (standard 
wire loop method). A standard bacteriological loopful 
of urine was spread over the surface of Cystine Lactose 
Electrolyte Deficient (CLED) agar plate. The loop used can 
transfer 0.002 mL of urine. After inoculation, the plates 
were left on the bench for 10 to 20 minutes to allow the 
urine to be absorbed into the agar medium. The plates 
were then inverted and incubated at 37 曟 for 18-24 hours. 
Using morphological and cultural features, the number of 
bacterial colony forming units was counted on each CLED 
agar medium. Plates containing 200 colony forming units 
(CFU) or more were considered to be significant bacteriuria 
because 200 CFU in 1/500 mL of urine is proportional to 105 
organisms per ml of urine. Pure isolates of resulting growth 
were identified using biochemical method as described by 
Holt et al[18].
2.4. Antibiotic susceptibility testing
  The agar diffusion technique as described by Bauer et 
al[19] was used. Five colonies of the test organisms were 
streaked on agar plates using sterile inoculating wire loop. 
The appropriate multi-disc depending on whether the 
test organism plated was a gram negative or grampositive 
organism was then placed firmly onto the surface of the dried 
plates, using sterile forceps. The plates were left at room 
temperature for one hour to allow diffusion of the different 
antibiotics from the disc into the medium. The plates were 
then incubated at 37 曟 for 18-24 hours. Interpretation of 
results was done using the zone sizes. Zones of inhibition 
greater than 10 mm were considered sensitive, 5-10 mm 
moderate sensitive and no zone of inhibition resistant.
2.5. Statistical analysis
  The data obtained were analysed using the Statistical 
Package for Social Sciences, version 17 (SPSS-17).
3. Results
  A total of 760 urine samples were collected and analysed 
for bacteriuria using urinalysis, then culture, microscopy, 
and sensitivity testing. Subjects were aged <18 (9), 18-22 
(141), 23-27 (194), 28-32 (183), 33-37 (165), 38-42 (64) and 
>42 (4). The parity of subjects were nullipara (178), primipara 
(141), P2 (161), P3 (131), P4 (77), and grandmultipara (72).
  A total of 111 samples yielded moderate or severe growth 
on culture after 48 hours, of which 62 samples were from 
nulliparous subjects. 649 samples yielded no growth or 
mixed growth of doubtful significance after culture for 48 
hours. Urinalysis results were positive for the presence of 
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NR and LE activity in 17 urine samples of the 111 samples 
that yielded moderate or severe growth on culture after 48 
hours. Urinalysis results were positive for the presence of NR 
and LE activity in 9 urine samples of the 649 samples that 
yielded no growth or mixed growth of doubtful significance 
after culture for 48 hours.
  The isolates identified on microscopy of the 111 samples 
which yielded moderate or severe growth on culture were 
Staphylococcus spp. (35), Proteus spp. (31), Klebsiella spp. (27), 
and Escherichia spp. (18). The microorganisms identified 
on microscopy of the 17 samples positive for the presence 
of NR and LE activity on urinalysis were Staphylococcus 
spp. (4), Proteus spp. (7), Klebsiella spp. (6), and Escherichia 
spp. (1). The sensitivity patterns of the various isolates are 
presented in Table 1.
Table 1
Sensitivity patterns of isolates.
Drugs/Isolates Flouroquinolones 毬 lactam antibiotics Nitrofurantoin Cotrimoxazole Tetracycline
Staph spp (35) 31 18 30 6 7
Proteus spp (31) 12 12 13 5 8
Klebsiella spp (27) 12 3 18 4 0
Escherichia spp (18) 9 9 13 0 0
4. Discussion
  The prevalence of ASB in pregnancy in this study is 
14.6%. The prevalence of ASB varies between the studies 
even within the same country. For instance, ASB in Nigerian 
studies ranges from 4% to 21%, depending on the population 
studied in different Nigerian provinces[20]. In Ethiopia 
and Ghana, the incidence of ASB was 9.3% and 7.3% 
respectively[21]. The prevalence of ASB is 6.1 % and 4.8% 
among pregnant women in Iran and United Arab Emirates 
respectively[22], and 12% in rural areas in Bangladesh[23]. 
This variation can be attributed to several factors such as 
the geographical variation, ethnicity of the subjects, setting 
of the study (primary care, community based, or hospitals), 
and the variation in the screening tests (urine dipstick, 
microscopy, culture).
  Escherichia coli is the most common pathogen associated 
with both symptomatic and asymptomatic bacteriuria[24], 
accounting for as much as 79%[21] of isolated uropathogens 
in reports. The predominance of Escherichia coli could be 
attributed to urinary stasis, which is common in pregnancy 
and since most (Escherichia coli) strains prefer that 
environment, to cause UTI. However, we found Escherichia 
coli to be the least common uropathogen isolated, compared 
with Staphylococcus spp., Proteus spp., and Klebsiella spp. 
The isolates showed a general sensitivity to the fluorinated 
quinolones and to nitrofurantoin; and poor antibacterial 
effects of the sequential anti folate, cotrimoxazole and the 
protein synthesis inhibitor, tetracycline.
  The penicillins have been shown to be safe in all trimesters 
of pregnancy, and have not been associated with increase 
in the rate of malformations of major birth defects[25], 
though high resistance rates limit its use as a single agent. 
The oral second generation cephalosporins (which are 
inactive against Enterococcus spp.) have also been shown 
to be relatively safe and non toxic in pregnancy[25]. The 
β-lactams are sometimes associated with allergic or 
anaphylactic reactions and the pharmacokinetic changes of 
pregnancy decrease plasma concentrations of β-lactams 
by up to 50%.
  Fluoroquinolones are uncommonly prescribed for the 
treatment of UTI due to concerns regarding the safety 
of this class of drugs which originated from reports of 
arthropathy in animal studies; such reports are rare in 
human cases. The safety of these drugs in pregnancy has 
been explored [26]. Based on existing data, fluoroquinolone 
exposure during human gestation is not associated with 
increased risk of major malformations, adverse effects in 
the fetal musculoskeletal system, spontaneous abortions, 
prematurity, intrauterine growth retardation, or postnatal 
disorders. However, because of the concern about the 
emergence of antibiotic-resistant pathogens with frequent 
use, fluoroquinolones should not routinely be employed as 
first-line agents in uncomplicated UTIs.
  Nitrofurantoin can theoretically induce hemolytic anemia 
in the fetus or newborn, particularly in those with glucose-
6-phosphate dehydrogenase deficiency; however, cases 
of this toxicity are rare[27]. Case-control, case series and 
meta-analysis studies shows that Nitrofurantoin is safe 
in all trimesters of pregnancy[28]. There is a low level of 
resistance to Nitrofurantoin among uropathogens (only a 
rate of 1%). The drawback that Nitrofurantoin only achieves 
therapeutic levels in the urine (so it cannot be used to 
treat pyelonephritis) makes its use in bacteriuria perfect. 
Nitrofurantoin is poorly active against Proteus spp. It may 
cause severe nausea and reduce compliance.
  Sulfamethoxazole can persist in neonatal circulation for 
several days after delivery if taken near term and there 
is a theoretical risk of sulfonamides increasing unbound 
bilirubin owing to competitive protein binding[29]. This 
displacement of bilirubin from albumin-binding sites 
and could cause severe jaundice leading to kernicterus 
Trimethoprim is a folic acid antagonist and its use during 
the first trimester has been associated with structural 
defects, such as neural tube and cardiovascular defects[30]. 
Trimethoprim-sulfamethoxazole (cotrimoxazole) should be 
avoided in pregnancy.
  As a result of chelation with Ca2+, tetracyclines bind 
to, and damage growing bones and teeth. Tetracyclines 
are deposited in newly formed teeth or bone in young 
children. If administered after 5 months gestation, they 
can be deposited in foetal teeth leading to fluorescence 
(discoloration of deciduous teeth), discoloration, and enamel 
dysplasia. They can impair liver function especially during 
pregnancy.
  Our results revealed that urinalysis could only identify 
bacteriuria in 17 of the 111 samples identified by culture. 
Neither the NR nor LE test showed appreciable sensitivity 
with poor negative predictive value (NPV). Theoretically the 
combined NR and LE tests should have better sensitivity and 
NPV values, but however still gave poor values. Urinalysis 
results were positive for the presence of NR and LE activity 
in 9 urine samples of the 649 samples that yielded no growth 
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or mixed growth of doubtful significance after culture for 
48 hours. Thus, the positive predictive value (PPV) and 
specificity of the screening test isn’t accurate. This isn’t in 
keeping with reports that the combined NR and LE dipstick test 
may provide an acceptable alternative to urine culture [31]. The 
NR test is an indirect measure of nitrate reducing bacteria, 
which includes all enterobacteriaceae, most non-fermenters 
and gram-negative cocci, provided the urine contains 
sufficient dietary nitrates and has been retained in the 
bladder for longer than 4 hours. The poor sensitivity of the 
NR test (false negatives) may be due to infections caused by 
gram-positive cocci like staphylococci.
  Although urine culture remains the gold standard for 
screening for and diagnosis of ASB in pregnant women, it 
is time, cost, and labour-intensive and patients may have 
difficulty providing uncontaminated samples for testing. An 
ideal screening test should be simple, rapid and accurate 
and must identify all positive cases, thus a sensitive test 
with a high NPV and specificity is desirable. Thus screening 
methods will find increased usefulness as full bacteriological 
analysis could be reserved for those patients who are 
symptomatic or have a positive screening test results.
  The prevalence of ASB in pregnant women attending the 
University of Port Harcourt Teaching Hospital antenatal 
clinic is 14.6%, with the predominant organism being 
Staphylococcus spp. Close attention should be given to the 
safety profiles of drugs used in treatment of ASB, and though 
urine culture remains the gold standard for screening for 
and diagnosis of ASB in pregnant women, it would be ideal 
to identify a rapid test with a high negative predictive value 
for ASB that could replace urine culture as a screening test.
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